CeGaT GmbH

We are a world leader in gene analyses for a wide range of medical, research and pharmaceutical applications. Since 2009, we have been helping doctors and patients find the genetic causes of rare diseases. We provide researchers and pharmaceutical companies with genetic analysis for clinical trials and medical innovation. We help oncologists and cancer patients find the best therapy option. We continue to drive science forward with our own insights. You can find our imprint under the following link: https://www.cegat.de/en/disclaimer/ Sie finden unser Impressum unter folgendem Link: https://www.cegat.de/impressum

Panel diagnostics,sequencing service,genetic testing,bioinformatics,single gene testing,array cgh,tumor diagnostics,genetic risk assessment,exome sequencing,genome sequencing,transcriptome sequencing,liquid biopsy,next generation sequencing,novaseq,cap/clia,tumor mutational burden,mody,genetic neurological disorders,genetic eye diseases,genetic cardiac diseases,and genetic kidney diseases

Cegat gmbh operates in the Hospitals and health care industry.

Cegat gmbh's revenue is 11m - 100m

Cegat gmbh has 51 - 200 employees.